Our results indicate that NEIL3 promotes NSCLC cell proliferation, invasion, and migration partially by regulating the classic PI3K/AKT/mTOR signaling pathway; thus, it might be a promising therapeutic target. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.